All In Biotech

Drug Trial Radar · NCT02706119

Insulin in Total Parenteral Nutrition

Subcutaneous Versus Intravenous Basal Insulin in Non-critical Hospitalized Diabetic Patients That Receive Total Parenteral Nutrition

Last checked: Nov 20, 2026Latest source record: May 24, 2018 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 163 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

163

Actual

Start

Jul 1, 2016

Primary completion

Mar 31, 2018

Study completion Apr 4, 2018

Sponsor

Lead sponsor
Fundación Pública Andaluza Progreso y SaludAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Mar 11, 2016

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Screening
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Analyze the level of metabolic control achieved with a routine of regular insulin in the parenteral nutrition (PN) reservoir in addition to subcutaneous glargine insulin, versus only regular insulin in the PN reservoir.

Conditions

  • Diabetes Mellitus

Interventions

  • Subcutaneous glargine insulinDrug

    Glargine insuline is an insulin analogue which has a prolonged duration of action. Insulin glargine is obtained by recombinant DNA technology in Escherichia coli.

  • Regular insulin added to TPN bagDrug

    Regular insulin is human insulin produced in Saccharomyces cerevisiae by recombinant DNA technology.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Basal blood glucose value before starting TPNTime frame: Before starting total parenteral nutrition
  2. Periodical blood glucoseTime frame: Every 6h during 15 days of treatment
  3. Variation of average blood glucose compared with total dose of insulinTime frame: In days 1, 5 and 15 of treatment
  4. Number of hypoglycaemiaTime frame: During TPN treatment up to 15 days
  5. Number of severe hypoglycaemiaTime frame: During TPN treatment up to 15 days
  6. Hypoglycemia blood glucose valuesTime frame: Through study completion, an average of 15 days.
  7. Hypoglycemia symptomsTime frame: Through study completion, an average of 15 days.

Locations

32 sites in 1 country. Site status is shown where the registry gives one.

  • Complejo Hospitalario Universitario de Albacete

    Albacete, Spain

  • Hospital General Universitario de Alicante

    Alicante, Spain

  • Hospital Universitario Infanta Cristina

    Badajoz, Spain

  • Hospital del Mar

    Barcelona, Spain

  • Hospital Universitario Bellvitge

    Barcelona, Spain

  • Hospital de Sant Joan Despi Moisès Broggi (Consorci Sanitari Integral)

    Barcelona, Spain

  • Hospital Universitario Reina Sofía

    Córdoba, Spain

  • Hospital Universitario de Guadalajara

    Guadalajara, Spain

  • Complejo Hospitalario de Jaén

    Jaén, Spain

  • Complejo Asistencial Universitario de León

    León, Spain

  • Hospital Universitario Gregorio Marañón

    Madrid, Spain

  • Fundación Jiménez Díaz

    Madrid, Spain

  • Hospital Clínico San Carlos

    Madrid, Spain

  • Hospital Regional Universitario de Málaga

    Málaga, Spain

  • Hospital Universitario Virgen de la Victoria

    Málaga, Spain

  • Hospital Universitario Nuestra Señora de la Candelaria

    Santa Cruz de Tenerife, Spain

  • Hospital Universitario Virgen del Rocío

    Seville, Spain

  • Hospital Universitario y Politécnico La Fe

    Valencia, Spain

  • Hospital Clínico Universitario de Valladolid

    Valladolid, Spain

  • Hospital Clínico Universitario Lozano Blesa

    Zaragoza, Spain

  • Hospital Universitario Miguel Servet

    Zaragoza, Spain

  • Hospital Arquitecto Marcide-Naval

    Ferrol, A Coruña, Spain

  • Hospital de Mérida

    Mérida, Badajoz, Spain

  • Hospital Son Llátzer

    Palma de Mallorca, Balearic Islands, Spain

  • Hospital General Mancha Centro

    Alcázar de San Juan, Ciudad Real, Spain

  • Hospital Universitario Principe de Asturias

    Alcalá de Henares, Madrid, Spain

  • Hospital Universitario de Fuenlabrada

    Fuenlabrada, Madrid, Spain

  • Hospital Universitario Severo Ochoa

    Leganés, Madrid, Spain

  • Hospital Universitario Puerta de Hierro

    Majadahonda, Madrid, Spain

  • Hospital Clínico Universitario Virgen de la Arrixaca

    El Palmar, Murcia, Spain

  • Complejo Hospitalario de Navarra

    Pamplona, Navarre, Spain

  • Hospital de Cabueñes

    Gijón, Principality of Asturias, Spain

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.